Invention Grant
- Patent Title: Pyridines, pyrimidines, and pyrazines, as BTK inhibitors and uses thereof
-
Application No.: US15499460Application Date: 2017-04-27
-
Publication No.: US10005784B2Publication Date: 2018-06-26
- Inventor: Lesley Liu-Bujalski , Ngan Nguyen , Hui Qiu , Reinaldo Jones , Igor Mochalkin , Richard D. Caldwell
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: EMD Serono Research and Development Institute
- Agent Dwight D. Kim
- Main IPC: A01N43/58
- IPC: A01N43/58 ; A01N43/60 ; A61K31/50 ; A61K31/495 ; C07D487/04 ; C07D471/04 ; A61K31/4985
Abstract:
The present invention relates to pyridine, pyrimidine, and pyrazine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
Public/Granted literature
- US20170226113A1 PYRIDINES, PYRIMIDINES, AND PYRAZINES, AS BTK INHIBITORS AND USES THEREOF Public/Granted day:2017-08-10
Information query
IPC分类:
